peoplePerson

James L. Gulley

Runs NCI's immuno-oncology clinical programme, from prostate cancer vaccines to bifunctional checkpoint fusion proteins.

Medical oncologist who led PROSTVAC and early bintrafusp alfa studies and coordinates immuno-oncology trials across NCI's intramural programme.

Role

Co-Director, Center for Immuno-Oncology, Center for Cancer Research

Institution

National Cancer Institute (NIH)

Specialisms

Genitourinary cancersCancer vaccinesBifunctional immunotherapies

Profiles

Papers

Title	Journal	Year
Phase III trial of PROSTVAC in asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer	Journal of Clinical Oncology	2019

Connected

Pages like this

not linked directly; found by shared links

Product
Sipuleucel-T
Shares Off-the-shelf cancer vaccines, Prostate cancer.
Person
Brigitte C. Widemann
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
Person
Louis M. Staudt
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
Person
Elizabeth M. Jaffee
Shares Off-the-shelf cancer vaccines, Immune checkpoint inhibitors.
Person
Raffit Hassan
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
Institution
Sidney Kimmel Comprehensive Cancer Center at Jefferson Health
Shares Off-the-shelf cancer vaccines, Prostate cancer.
Person
Nirali N. Shah
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
Person
Padmanee Sharma
Shares Bladder & urothelial cancer, Immune checkpoint inhibitors, Prostate cancer.

cancers

2

Bladder & urothelial cancer Prostate cancer

technologies

2

Immune checkpoint inhibitors Off-the-shelf cancer vaccines

institutions

2

National Cancer Institute (NIH)NCI Center for Cancer Research (intramural programme)